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A sticky business
Many proteins that resemble Bcl-2 or bind to it have been found using
techniques that reflect interactions in vitro or depend on DNA homology,
but we still do not know how this master regulator of apoptosis works.
In the beginning there was just Bcl-2. Discovery of the
effects of this first and best-known inhibitor of cell sui-
cide prompted an intense search for its mode of action.
Now, several proteins have been identified that have simi-
lar structures, and a number of proteins that interact with
Bcl-2 have been found. These observations suggest there
is a complex network of wrestling proteins, the balance
of which determines the fate of the cell. The mechanism
of action of Bcl-2, however, remains enigmatic.
A remarkably large and diverse array of agents can pro-
voke cells to kill themselves by apoptosis. In a significant
proportion of instances, this response can be blocked by
expression of the bcl-2 gene, yet we still do not know how
the Bcl-2 protein works. Experiments with Caenorhabditis
elegans show that Ced-9, the nematode homolog of Bcl-2
[1,2], inhibits a cell death process that requires the cys-
teine protease Ced-3. In mammals the process is similar:
Bcl-2 can block cell death mediated by protease homologs
of Ced-3, such as interleukin-lp3 converting enzyme
(ICE), Nedd2 and CPP32, but how this is achieved, and
the nature of the molecular link between the inhibitors
and mediators of cell death are unknown [3-5].
Experiments aiming to discover how Bcl-2 works are, for
example, tracing the molecular chain outward from
Bcl-2, protein by protein, using techniques such as
immunoprecipitation and the yeast two-hybrid system
(which assesses the interaction between two proteins by
monitoring whether it is sufficient to drive transcription
when the two are fused to two separate parts of a tran-
scriptional activator). The hope is that such studies will
eventually lead downstream to the effector molecules that
implement cell death, or upstream to control mecha-
nisms. This effort has so far yielded a large number of
molecules, some of which bear structural similarity to
Bcl-2, and analysis of the genes and their encoded
products is under way.
The Bcl-2 protein has a hydrophobic carboxyl terminus
that localizes it to intracellular membranes, leaving the
remainder of the protein in the cytosol [6] where it can
interact with other molecules. Immunoprecipitation of
Bcl-2 has shown that it is often bound to a protein, des-
ignated Bax, that shares sequence similarity with Bcl-2
but which acts to antagonize Bcl-2's anti-cell-death
effects [7]. Elegant mutagenesis experiments showed that
mutations in Bcl-2 that prevented it from associating
with Bax also stopped Bcl-2 from blocking cell death [8].
The simplest interpretation of these results is that Bax is
required for apoptosis, and that Bcl-2 protects cells from
death by binding to Bax. The picture may be more com-
plex, however, as mutations of the analogous residues in
Ced-9, the nematode Bcl-2 homolog, have the opposite
effect: they increase its death-sparing activity [9].
Other proteins resembling Bcl-2 - Bcl-x and Bak
[10-13] - were found by searching for genes with
sequences similar to bcl-2 using Southern DNA
hybridization analysis or the polymerase chain reaction
(PCR). Some of the encoded proteins act like Bcl-2 and
prevent cell death (Bcl-xl, the long form of Bcl-x),
whereas others are pro-cell death (Bcl-xs (short) and
Bak), like Bax (Table 1; Fig. 1). Direct screening for pro-
teins that can interact with Bcl-2, using the yeast two-
hybrid system, yielded Bad, which also resembles Bcl-2
in sequence [14]. Bad binds to both Bcl-2 and Bcl-xl,
and antagonizes the protection given by Bcl-xl, but not
that of Bcl-2. Yang et al. [14] speculate that Bad acts to
displace Bax from Bcl-xl, thereby freeing Bax to sensitize
cells to suicide-provoking stimuli.
The now extensive Bcl-2-like family also includes three
viral genes - BHRF1 from Epstein-Barr Virus,
LMW5-HL from African swine fever virus, E1B 19kD
from adenovirus [15-18] - along with two genes
expressed in myeloid cells that were serendipitously found
Fig.1. Bcl-2 is related to, and interacts with, a complex array
of inhibitors and promoters of cell death. See text and Table 1
for details.
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to resemble bcl-2 (Al and Mcl-1) [19, 20], and ced-9, the
gene from C. elegans that acts like bcl-2 to control cell
death in the worm. These proteins bear regions desig-
nated Bcl-2 homology domains (BH) 1 and 2 [8]. Muta-
genesis and yeast two-hybrid experiments show that Bcl-2
family members can form homodimers and heterodimers
via binding of these domains to each other [14,21].
The yeast two-hybrid system, along with interaction
assays using proteins expressed from bacteriophage
libraries, has been used to find many other proteins that
can bind to Bcl-2. R-Ras was the first to be found in this
way, a result which suggested that R-Ras, which belongs
to a family of small GTPases involved in intracellular sig-
nal transduction, might provide a link between signalling
from growth factor receptors and cell survival [22].
Unfortunately, experiments supporting a physiological
role for the interaction of Bcl-2 and R-Ras have been
disappointingly unforthcoming. Another observation that
lent support to the involvement of Bcl-2 with signalling
molecules has been co-immunoprecipitation of Bcl-2 and
the Raf-l kinase from mammalian cells [23], but once
again confirmatory evidence has yet to appear, and an
interaction between Bcl-2 and Raf-1 could not be
demonstrated using the yeast two-hybrid system [21].
Nipl, Nip2 and Nip3 [24] do not resemble Bcl-2 but
can bind to it as well as to E1B 19 kD from adenovirus,
but little is known about their function. Nip 1 is a 228
amino-acid protein with a putative membrane-spanning
domain, and it has a short region that resembles some
phosphodiesterases. Nip2 has 315 amino acids and shares
significant homology with the GTPase-activating protein
RhoGAP, but the region of similarity does not include
the functional domain of RhoGAP. Nip3 is 194 amino-
acids long and has a putative transmembrane domain; it is
very similar to rat calbindin-D, a cytosolic vitamin D-
dependent calcium-binding protein. Yeast two-hybrid
screens using E1B 19 kD as the bait also yielded the
nuclear membrane protein lamin a/c, a finding which
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may have significance as nuclear changes are an early fea-
ture of apoptosis [13]. Yet another interacting protein,
Bag-i, was found by probing phage expression libraries
with Bcl-2 protein [25]. Bag-1 has no similarity to Bcl-2
or other family members, and offers only slight protec-
tion against apoptosis when expressed on its own, but it
synergizes with Bcl-2 to enhance its protective capacity.
The number of Bcl-2-like and interacting proteins is
extensive - which is not surprising given that these pro-
teins control the fate of the cell. We still have a long way
to go in understanding cell death, however, as despite
their rapid identification, almost nothing has been
revealed about how these proteins function.
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